Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?

To: James Strauss who wrote (5067)	9/12/1999 9:13:00 PM
From: Sergio H	Read Replies (1) \| Respond to of 13094

IVX I've been in this stock for a while as you know. Keeps hitting new highs. The fundamentals are excellent. The CEO likes it so much, he keeps buying more shares for himself and the Co. Ivax is a successful turnaround story. Forbes featured IVX in their Sept issue. and the stock made Individual Investors Magic 25 list in Sept. Gruntal keeps increasing earning estimates and investors applauded Ivax's decision not to go ahead with Internet pharmacy plans. There's a lot more to like. IVX has some interesting drugs that have promise in new applications and the Co. is considered a very likely buyout candidate. Sergio